As an aid in diagnosing oligodendroglioma tumors and predicting the response of an oligodendroglioma to therapy.
The test may be useful in tumors with a complex "hybrid" morphology requiring differentiation from pure astrocytomas to support the presence of oligodendroglial differentiation/lineage.
The test is indicated when a diagnosis of olugodendroglioma, both low-grade World Health Organization ([WHO], grade II) and anaplastic ([WHO], grade III) is redndered. The test also is strongly recommended in mixed oligoastrocytomas.